However, several studies have indicated that antibiotic treatment is associated with a worsening of the clinical outcomes of PD-1 in cancer treatment, including lung cancer (Derosa et al., 2018; Huemer et al., 2018; Zhao et al., 2019). This evidence concerns the gene PDCD1 and lung cancer.